Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Filippi

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Frontiers in Psychology|November 22, 2018
Impact of Language Experience on Attention to Faces in Infancy: Evidence From Unimodal and Bimodal Bilingual InfantsEvelyne Mercure, Isabel Quiroz, Laura Goldberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2021
Prognostic Value of Whole-Body PET Volumetric Parameters Extracted from <sup>68</sup>Ga-DOTATOC PET/CT in Well-Differentiated Neuroendocrine TumorsPhilippe Thuillier, Virginia Liberini, Serena Grimaldi, et al.
NPJ Precision Oncology|March 9, 2022
Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitorsEnrico Berrino, Roberto Filippi, Clara Visintin, et al.
Trials|March 13, 2021
Clinical research and burnout syndrome in Italy - only a physicians' affair?Celeste Cagnazzo, Roberto Filippi, Giulia Zucchetti, et al.
Cancers|March 20, 2019
Improvement of Metastatic Colorectal Cancer Patient Survival: Single Institution ExperienceElisabetta Fenocchio, Federica Colombi, Maria Grazia Calella, et al.
Cancer|November 6, 2015
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)Francesco Leone, Donatella Marino, Stefano Cereda, et al.
Oncology Reports|December 23, 2022
Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT)Pasquale Lombardi, Giacomo Aimar, Caterina Peraldo-Neia, et al.
Acta Oncologica (Stockholm, Sweden)|July 20, 2021
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapyRoberto Filippi, Francesco Montagnani, Pasquale Lombardi, et al.
International Journal of Cancer|June 12, 2020
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancerCindy Neuzillet, Andrea Casadei-Gardini, Bertrand Brieau, et al.
Journal of Chemotherapy (Florence, Italy)|July 27, 2021
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysisRoberto Filippi, Francesco Leone, Lorenzo Fornaro, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Frontiers in Psychology|November 22, 2018
Impact of Language Experience on Attention to Faces in Infancy: Evidence From Unimodal and Bimodal Bilingual InfantsEvelyne Mercure, Isabel Quiroz, Laura Goldberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2021
Prognostic Value of Whole-Body PET Volumetric Parameters Extracted from <sup>68</sup>Ga-DOTATOC PET/CT in Well-Differentiated Neuroendocrine TumorsPhilippe Thuillier, Virginia Liberini, Serena Grimaldi, et al.
NPJ Precision Oncology|March 9, 2022
Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitorsEnrico Berrino, Roberto Filippi, Clara Visintin, et al.
Trials|March 13, 2021
Clinical research and burnout syndrome in Italy - only a physicians' affair?Celeste Cagnazzo, Roberto Filippi, Giulia Zucchetti, et al.
Cancers|March 20, 2019
Improvement of Metastatic Colorectal Cancer Patient Survival: Single Institution ExperienceElisabetta Fenocchio, Federica Colombi, Maria Grazia Calella, et al.
Cancer|November 6, 2015
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)Francesco Leone, Donatella Marino, Stefano Cereda, et al.
Oncology Reports|December 23, 2022
Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT)Pasquale Lombardi, Giacomo Aimar, Caterina Peraldo-Neia, et al.
Acta Oncologica (Stockholm, Sweden)|July 20, 2021
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapyRoberto Filippi, Francesco Montagnani, Pasquale Lombardi, et al.
International Journal of Cancer|June 12, 2020
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancerCindy Neuzillet, Andrea Casadei-Gardini, Bertrand Brieau, et al.
Journal of Chemotherapy (Florence, Italy)|July 27, 2021
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysisRoberto Filippi, Francesco Leone, Lorenzo Fornaro, et al.
Pageof 6